Search results
Moderna turns to AI to change how its employees work
CIO Dive· 4 days agoModerna is betting big on bespoke artificial intelligence assistants. The biotechnology company on Wednesday said it has expanded a partnership with OpenAI, the buzzy creator ...
Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead
Bloomberg via Yahoo Finance· 13 hours ago(Bloomberg) -- Novo Nordisk A/S’s reign as Europe’s most valuable company “leaves no room to...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 12 hours agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may now be “contagious, ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
These Stocks Are Moving the Most Today: Tesla, SoFi, Alphabet, Apple, Paramount, AMC, Fulton...
Barrons.com· 3 hours agoChina tentatively approves Tesla’s plan to launch ‘Full Self-Driving’ software in the country, and...
A Fed meeting, jobs report, and more Big Tech earnings: What to know this week
Yahoo Finance via AOL· 10 hours ago...), Block (SQ), Booking Holdings (BKNG), Coinbase (COIN), Cigna (CI), ConocoPhillips (COP),...
State’s highest paid CEO reports major drop in compensation - Boston Business Journal
The Business Journals· 3 days agoLast year, Douglas Ingram, the president and CEO of Sarepta Therapeutics (Nasdaq: SRPT), reported...
Moderna Inc [MRNA] Shares Fall
Knox Daily· 3 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $1,550,703 were sold by AFEYAN NOUBAR on ...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 11 hours agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 6 days agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.